PR Newswire
15 Jun 2022, 23 GMT+10
The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport.
GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA methylation detection product developed by AnchorDx for the early diagnosis of lung cancer, recently completed the procedure for EU IVDD CE Marking, and obtained IVD reagents licensing signed and issued by the CIBG of Ministry of Health, Welfare and Sport in the Netherlands. The license number is NL-CA002-2022-71591.
PulmoSeekTM is applicable for the benign and malignant diagnosis of people with 5-30mm pulmonary nodules. In the earlier stage of prospective clinical studies at 14 centers, the product's excellent performance was well verified in the following:
According to GLOBOCAN 2020 data released by the International Agency for Research on Cancer (IARC), lung cancer is the leading cause of cancer deaths (18%) with more than 2.2 million new cases and 1.8 million deaths annually worldwide. As a screening technology for lung cancer, LDCT has been widely recognized by domestic and international clinical guidelines, but the precise management of patients with pulmonary nodules after LDCT screening has also become an urgent clinical problem to be solved.
PulmoSeekTM Lung Cancer Early Detection Assay can achieve early diagnosis and treatment of lung cancer through accurate diagnosis of patients with benign and malignant pulmonary nodules. Currently, several of AnchorDx's products have obtained relevant IVD-related qualifications from US FDA and European Medicines Agency (EMA). PulmoSeek's access permit for the EU market will further promote this innovative precision medical product to benefit more patients with pulmonary nodules around the world forthwith.
About AnchorDx
AnchorDx is a world-leading developer of cancer screening and early detection solutions based on methylation NGS technology. AnchorDx strives to revolutionize single/multi/pan-cancer early screening, detection technologies, and products. The current product pipeline encompasses more than 70% of all cancers.
CONTACT : PR@anchordx.com
SOURCE Guangzhou AnchorDx Co., LTD
Get a daily dose of Malaysia Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.
More InformationSHAN STATE, Myanmar - Locals claim that the Pa-O National Organisation (PNO) militia has been forcibly recruiting members from villages ...
DHAKA, Bangladesh - The Haji Yunus Ali School and College in Ashulia, Savar, has suspended a student hanging out with ...
KATHMANDU, Nepal - According to the Department of Forests and Soil Conservation, 90 settlements in Salyan are at high risk ...
LAHORE, Pakistan - FIFA, the world governing body of football, lifted Pakistan's suspension on Thursday and extended the mandate of ...
MANDALAY, Myanmar - On Wednesday, Junta authorities arrested three more Mandalay-based lawyers representing political detainees after leaving their clients' hearings ...
DHAKA, Bangladesh - Tarique Rahman's support for Bangabandhu Sheikh Mujib's killers has been criticized by Sheikh Hasina. The murderers of ...
SYDNEY, NSW, Australia - Stocks in Asia generally moved higher on Monday despite continuing concerns over a potential global recession.U.S. ...
WASHINGTON D.C.: Due to surging food prices, summer cookouts for the U.S. Independence Day holiday are more expensive, forcing Americans ...
WASHINGTON D.C.: In a cardboard box factory outside Baltimore, people have been walking into the office of Paul Centenari, chief ...
DELFT, Netherlands: IKEA officials said this week that the furniture retailer's warehouses in Europe are as full as they were ...
NEW YORK CITY, New York: After the first six months of 2022, the S&P 500 recorded a loss of 20.6 ...
WASHINGTON D.C.: Due to the record high trade deficit and a resurgence in COVID-19 infections that curbed spending on services, ...